CVE:PDP Pediapharm (PDP) Stock Price, News & Analysis → Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (From Paradigm Press) (Ad) Free PDP Stock Alerts C$0.30 +0.01 (+1.69%) (As of 12/18/2018) Add Compare Share Share Today's RangeC$0.29▼C$0.3150-Day RangeC$0.30▼C$0.3052-Week RangeC$0.25▼C$0.49Volume26,000 shsAverage Volume100,369 shsMarket CapitalizationC$66.36 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Pediapharm alerts: Email Address Ad Porter & CompanyThe new masters of energyAccording to one source, this new grid could soon provide energy to “one billion people in the world who don’t have access to electricity right now.” And early investors could make a fortune.Click here to get all the details. About Pediapharm Stock (CVE:PDP)Pediapharm Inc. operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children. The company was incorporated in 2003 and is headquartered in Verdun, Canada.Read More PDP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PDP Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive PDP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pediapharm and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:PDP CUSIPN/A CIKN/A Webwww.pedia-pharm.com Phone+1-514-7622626FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio30.00 P/E Growth150Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio186.87 Current Ratio1.12 Quick Ratio0.71 Sales & Book Value Annual SalesC$11.16 million Price / Sales5.95 Cash FlowC$0.01 per share Price / Cash Flow23.08 Book ValueC($0.01) per share Price / Book-23.08Miscellaneous Outstanding Shares221,194,000Free FloatN/AMarket CapC$66.36 million OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Sylvain Chretien (Age 54)Pres, CEO & Director Mr. Roland BoivinChief Financial OfficerMr. Richard LabelleVP of Sales & MarketingMr. Benoît Hébert (Age 50)VP of Bus. Devel. & Licensing Mr. Normand Chartrand (Age 59)Consultant Key CompetitorsVIVO CannabisCVE:ABCNFennec PharmaceuticalsTSE:FRXEmblemCVE:EMCMedicenna TherapeuticsTSE:MDNABriaCell TherapeuticsCVE:BCTView All Competitors PDP Stock Analysis - Frequently Asked Questions How have PDP shares performed in 2024? Pediapharm's stock was trading at C$0.30 on January 1st, 2024. Since then, PDP shares have increased by 0.0% and is now trading at C$0.30. View the best growth stocks for 2024 here. Is Pediapharm a good dividend stock? Pediapharm (CVE:PDP) pays an annual dividend of C$0.14 per share and currently has a dividend yield of 0.00%. What other stocks do shareholders of Pediapharm own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pediapharm investors own include eMagin (EMAN), Eleven Biotherapeutics (EBIO), Coro Mining (COP), Champion Iron (CIA), Anavex Life Sciences (AVXL), AVEO Pharmaceuticals (AVEO), Asterias Biotherapeutics (AST) and Apellis Pharmaceuticals (APLS). How do I buy shares of Pediapharm? Shares of PDP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:PDP) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pediapharm Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pediapharm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.